DIŞSALLIK VE COVİD 19 AŞISININ OPTİMUM ÜRETİM SORUNU

Year 2022, Volume: 10 Issue: 2, 0 - 0

Tuğba Dayıoğlu Yılmaz Aydın

https://doi.org/10.52122/nisantasisbd.1171178

Abstract

2019 yılı sonunda Çin’in Wuhan kentinde ortaya çıkan COVID-19 salgını, tüm dünyayı etkisi altına almıştır. Salgının
pandemiye dönmesiyle birlikte birçok sektörü olduğu gibi havacılık sektörünü de olumsuz yönde etkilemiştir. Hava
taşımacılığı yapan işletmeler bu süreçte pazarlama stratejilerini farklılaştırarak ekonomik kayıplarını en az düzeyde
tutmaya gayret etmiştir. Bu çalışmada yarı yapılandırılmış nitel araştırma tekniği ile Türkiye’deki havacılık
sektöründe yer alan işletmelerin COVID-19 pandemisinden önce ve pandemi sürecinde uyguladıkları pazarlama
stratejileri ortaya koyularak karşılaştırma yapılmış ve önerilerde bulunulmuştur.

Keywords

COVID-19, Pazarlama Stratejileri, Havacılık, Havayolu Pazarlaması

EXTERNALITY AND THE PROBLEM OF OPTIMUM PRODUCTION OF THE COVID 19 VACCINE

Abstract

The COVID 19 pandemic, a new type of coronavirus, started about a year and a half ago. The rapidly developing COVID-19 pandemic has not only put many countries in the world into a health crisis; but also increasingly brought along economic and social crises. According to economic theory, the optimum production level of goods that emit positive externalities under free market conditions remains below the socially desirable amount. Since externality requires consideration of societal benefits and costs rather than private benefits and private costs, the state should be a regulator in the market. The COVID 19 vaccine is heavily subsidized and consumption expenditures are insufficient and covered by the public. Despite this, a proposal to waive the intellectual property right was put forward to ensure social immunity as soon as possible by increasing the rate of vaccination at the global level; however, no consensus has been reached. In this study, the lack of COVID 19 vaccine supply and how to remove the restrictions on this issue are discussed. In the first chapter, the concept of public goods is explained in detail. The subject of the second part is the intervention of the state in the production of externalities and goods that create externalities. In the third and last part, the inadequacy of the COVID 19 vaccine supply and the measures to be taken to increase the supply is discussed.

Keywords

: COVID-19, Marketing strategies, Aviation industry, Airline marketing

References

• Saksena, N. (2021). “Global justice and the COVID-19 vaccine: Limitations of the framework of the public goods”, Global Public Health, https://pubmed.ncbi.nlm.nih.gov/33764847
• Altvater, E. (2003). “Was passiert, wenn öffentliche Güter privatisiert werden?”, Peripherie Nr. 90/91, Verlag Westfälisches Dampfboot, Münster.
• Barış, A. & Barlas, E. (2017). “Kamu Maliyesi Teorisinde Küresel Kamusal Mallar”, Gaziosmanpaşa Üniversitesi Sosyal Bilimler Araştırmaları Dergisi, 12(1), 129-152.
• Blankart, B. C. (1998). Öffentliche Finanzen in der Demokratie, 3. Auflage, Verlag Vahlen, München.
• Brümmerhoff, D. (2001). Finanzwissenschaft, 8. Auflage, R. Oldenbourg Verlag, München.
• Durmuş, M. (2006). “Sosyal (Kamusal) Malların Yeniden Tanımlanması Gereği”, Ekonomik Yaklaşım, 17(59), 65-97.
• Feachem, R. & Sachs, J. D. (2002). “Global Public Goods for Health”, The Report of Working Group 2 of the Commission on Macroeconomics and Health, World Health Organization, Geneva.
• Göker, Z. (2008). “Kamusal Mallar Tanımında Farklı Görüşler”, Maliye Dergisi, (155), 108-118.
• Kim, H. (2021). “We need people’s WHO to solve vaccine inequity, and we need it now”, BMJ Global Health, https://gh.bmj.com/content/6/7/e006598, Erişim: 07.07.2021.
• Krishtel, P. & Malpani, R. (2021). “Suspend intellectual property rights for covid-19 vaccines”, the BMJ, https://www.bmj.com/content/373/bmj.n1344, Erişim: 24.07.2021.
• Licht, G. & Wambach, A. (2021). “Wie kann die weltweite Impfstoffproduktion gesteigert werden?”, Wirtschaftsdienst 101. Jahrgang, Heft 6, 406–407.
• Long, D. & Woolley, F. (2009). “Global Public Goods: Critique of a UN Discourse”, Global Governance, 15 (1), 107-122.
• Moon, S., Rottingen, J. A. & Frenk, J. (2017). “Global public goods for health: weaknesses and opportunities in the global health system”, Health Economics, Policy and Law, 12, 195–205.
• Musgrave, R., Musgrave, P. B. & Kullmer, L. (1994). “Die öffentlichen Finanzen in Theorie und Praxis” 1, Band 1, 6., aktualisierte Auflage, Mohr, Tübingen.
• Oral, B. G. (2014). “Sağlık Hizmetlerinin Küresel Kamusal Mal Olarak Değerlendirilmesi: Uluslararası Örgütler”, Finans Politik & Ekonomik Yorumlar, 51(588), 78-96. 24.06.2021.
• Samuelson, P. A. (1954). “The Pure Theory of Public Expenditure”, The Review of Economics and Statistics, 36(4), 387-389.
• Samuelson, P. A. (1955). “Diagrammatic Exposition of a Theory of Public Expenditure”, The Review of Economics and Statistics, 37(4), 350-356.
• Sarkar, P. & Das, S. (2021). “Essay on COVID-19 vaccine supply chains”, Informs https://www.informs.org/Publications/OR-MS-Tomorrow/Essay-on-COVID-19-vaccine-supplychains, 8.06.2021.
• Seçer, H. E. & Şar, S. (2019). “İlaçta Patent ve Sağlığa Erişim Hakkı”, Ankara Üniversitesi Eczacılık Fakültesi Dergisi, 43(3), 274-284.
• Stiglitz, J. E. (2000). Economics of the Public Sector, Third Edition, W.W. Norton & Company, New York/London.
• Ulbrich, H. H. (2003). Public Finance in Theory and Practice, Second edition, Routledge, New York.
• Yardım, M. (2020). “Enfeksiyon Hastalıklarında Dışsallıklar”, Ed. D. Aslan, Yeni Koronavirüs Hastalığı (COVİD 19): Öne Çıkan Konular, Hacettepe Üniversitesi Yayınları, 93-100.
• Yılmaz, E. B. & Yaraşır, S. (2011). “Bir Küresel Kamusal Mal Olarak Sağlık ve Finansmanında Resmi Kalkınma Yardımlarının Rolü”, İstanbul Üniversitesi, İktisat Fakültesi Maliye Araştırma Merkezi Konferansları, 55. Seri / Yıl 2011.
• Our World in Data, (2021, 07. 05). https://ourworldindata.org/covid-vaccinations .